Sorry, you need to enable JavaScript to visit this website.
Organisation

Office of Impact Analysis (Australia)

Acronym:
OIA

On the 18th of November 2022, the Office of Best Practice Regulation was renamed to the Office of Impact Analysis. 

Assessment

Australian screen content requirements for subscription video on demand services


The Australian Government reiterated its election commitment to introduce requirements for Australian screen content on subscription video on demand (SVOD) services. This Impact Analysis considers two options to address investment in Australian content. A regulatory model requiring SVODs to invest at least 10% of their total program expenditure in Australia is considered to be the...
Assessment

Resolution approach for income apportionment: impact analysis


Income apportionment was a long-standing practice of the Australian Government, dating back to the early 1990s, adopted to calculate social security debts. The historical use of income apportionment is now understood to be generally unlawful. This Impact Analysis considers a number of options for resolving historical debts calculated using income apportionment.
Assessment

Regulation impact statement: Home Guarantee Scheme


The Home Guarantee Scheme (HGS) assists individuals into home ownership. This Impact Analysis Equivalent has been prepared to inform the Government’s decision to expand the Australian Government's support through the HGS to all first home buyers. Treasury estimates the proposal will increase average regulatory costs by $5.38 million per year, over ten years.
Assessment

National Child Safety Review: Decision Regulation Impact Statement


The problem examined in this Decision Regulation Impact Statement (D-RIS) is that more could be done to better support services to protect children attending an education and care service, with a focus on improving child safety. Several policy options have been identified in the D-RIS, including regulatory and non-regulatory approaches, to improve child safety.
Assessment

Reduction of the Pharmaceutical Benefits Scheme (PBS) general patient co-payment to $25


This impact analysis supports the Australian Government's consideration of a reduction to the Pharmaceutical Benefits Scheme (PBS) general co-payment. The analysis compares the general patient co-payment reduction to $25 against the status quo. The proposal is estimated to save patients $784.6 million over four years from 2025–26.

ADVERTISEMENT